about
Rallybio Corp is a clinical-stage biotechnology company engaged in the development of therapeutic candidates for severe and rare diseases. It focuses on the treatment of conditions related to complement dysregulation and hematologic disorders. The co...
Read More
10.91
0.11
(1.02%)
137.7K
XNAS Volume
High vol.+gain this week
XNAS 06 Mar, 2026 4:30 PM (EST)
Board Meeting
The next board meeting for Rallybio Corp is on 13 Mar 2026 for the purpose of Rallybio Corp Fourth Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Bullish
Rallybio Corp Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..